Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
SEC
Surrozen (NASDAQ:SRZN) reported quarterly losses of $(8.36) per share which missed the analyst consensus estimate of $(1.14) by...
On October 14, 2025, Surrozen, Inc. (the "Company") received notice from TCGFB, Inc. ("TCGFB") that TCGFB has e...
-SEC Filing
Surrozen (NASDAQ:SRZN) reported quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $(1.11) by 3...
Newly granted patent is part of the expanding intellectual property portfolio directed to:-generating novel and selective Wnt s...
HC Wainwright & Co. analyst Matthew Caufield reiterates Surrozen (NASDAQ:SRZN) with a Buy and maintains $32 price target.
Surrozen (NASDAQ:SRZN) reported quarterly losses of $(7.43) per share which missed the analyst consensus estimate of $(1.78) by...
HC Wainwright & Co. analyst Matthew Caufield reiterates Surrozen (NASDAQ:SRZN) with a Buy and maintains $32 price target.
